Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
HES 130/0.4 Nephrotoxicity in Elderly Orthopedic Surgery Patients
NCT02361736Completed
- Start
- Mar 2015
- Primary completion
- Dec 2015
- Modality
- Polymer-based Nanoparticles, Lipid-based Nanoparticles, Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial of hetastarch in hypovolemia (2 arms). Primary endpoints: Neutrophil Gelatinase-Associated Lipocalin in Urine at 5 days, Interleukin-18 in Urine at 5 days and 2 more. Started Mar 2015; status: completed.
02
Drugs
hetastarch
03
Conditions
hypovolemia
Beyond the preview
Go deeper on NCT02361736.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02361736.